Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3355 |
|
Actual shortage: | 217 (6%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 335 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
61 (25%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-AMLODIPINE-ATORVASTATIN | 5MG 10MG | TABLET | Resolved | 2018-02-01 | 2018-07-03 | 37945 |
APO-AMLODIPINE-ATORVASTATIN | 5MG 40MG | TABLET | Resolved | 2021-04-23 | 2021-05-26 | 137956 |
APO-AMLODIPINE-ATORVASTATIN | 10MG 10MG | TABLET | Resolved | 2021-05-07 | 2021-05-26 | 138951 |
APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2021-05-07 | 2021-05-26 | 138954 |
APO-AMLODIPINE-ATORVASTATIN | 40MG 10MG | TABLET | Resolved | 2021-05-14 | 2021-05-26 | 139400 |
APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2021-08-27 | 2021-11-19 | 144656 |
APO-AMLODIPINE-ATORVASTATIN | 20MG 10MG | TABLET | Resolved | 2021-10-01 | 2021-11-15 | 146500 |
APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2021-10-29 | 2021-11-08 | 148491 |
APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2022-02-04 | 2022-04-01 | 154168 |
APO-AMOXI | 500MG | CAPSULE | Resolved | 2019-10-23 | 2019-11-05 | 97034 |
APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2020-01-08 | 2020-07-30 | 102528 |
APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2020-03-04 | 2020-06-24 | 107690 |
APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2020-07-08 | 2020-07-24 | 119693 |
APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Actual shortage | 2025-05-08 | 2025-05-08 | 256914 |
APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2020-11-04 | 2021-01-29 | 127751 |
APO-AMOXI | 500MG | CAPSULE | Resolved | 2024-12-05 | 2025-01-03 | 244926 |
APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2022-06-17 | 2024-02-14 | 162918 |
APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2022-08-12 | 2024-02-14 | 166621 |
APO-AMOXI | 500MG | CAPSULE | Resolved | 2022-11-27 | 2023-01-06 | 175904 |
APO-AMOXI | 250MG | CAPSULE | Resolved | 2022-12-05 | 2023-04-14 | 177129 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
APO-CARVEDILOL | 25MG | TABLET | Discontinued | 2024-01-26 | 2024-01-27 | 217504 |
APO-CARVEDILOL | 6.25MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217499 |
APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |
APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-08-06 | 217493 |
APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
APO-CEFPROZIL | 250MG | TABLET | Discontinued | 2019-01-04 | 2019-02-21 | 71195 |
APO-CEFPROZIL | 500MG | TABLET | Discontinued | 2018-04-04 | 2018-10-05 | 44945 |
APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Discontinued | 2018-12-20 | 2018-12-21 | 70250 |
APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60385 |